Return on equity ROE
16 %
Last period ROE
11%
ROE has increased in 5 years
What is ROE ?
The return on equity ratio shows how much net profit a company earns per unit of equity. To calculate the company's rating, the return on equity adjusted for the average level of financial leverage for 3 years is taken into account. The value of 20% is the benchmark for Eyestock Rating calculation.
See also Neurocrine
Company Analysis
NBIX valuation, rating, competitors, insights and company profile
Eyestock Rating
NBIX financial analysis by Eyestock methodology
Valuation
NBIX valuation using historical relative method
Financials
NBIX revenue, earnings, ROE, ROIC and other financials
Statements
NBIX Income Statements, Balance Sheet and Cash Flow Statements
Dividends
NBIX dividend yield and annual dividend
What is ROE ?
The return on equity ratio shows how much net profit a company earns per unit of equity. To calculate the company's rating, the return on equity adjusted for the average level of financial leverage for 3 years is taken into account. The value of 20% is the benchmark for Eyestock Rating calculation.
What is ROE of Neurocrine ?
Neurocrine`s ROE for the last twelve months ended 2024-09-30 is 16 %